MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by VIVEROS, O. H.
Right arrow Articles by KIRSHNER, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VIVEROS, O. H.
Right arrow Articles by KIRSHNER, N.

Molecular Pharmacology, Vol 7, 434-443, Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics

Mechanism of Secretion from the Adrenal Medulla

VI. Effect of Reserpine on the Dopamine beta-Hydroxylase and Catecholamine Content and on the Buoyant Density of Adrenal Storage Vesicles

O. H. VIVEROS 1, L. ARQUEROS 1, and N. KIRSHNER 1

1 Department of Biochemistry , Duke University, Medical Center, Durham, North Carolina 27706

The possibility of differentiating between chromaffin vesicles with different catecholamine contents was tested by studying the distribution of rabbit adrenal dopamine beta-hydroxylase (EC 1.14.21) and catecholamines, and the buoyant densities of the catecholamine storage vesicles after isopycnic centrifugation of crude storage vesicle fractions in sucrose density gradients. Catecholamine storage vesicles were prepared from adrenal glands of untreated rabbits, rabbits which had received chlorisondamine chloride (10/kg intraperitoneally) to block ganglionic transmission, and rabbits which had received both chlorisondamine chloride and reserpine (1 mg kg). Adrenal glands were examined 1 day after treatmenmt with chlorisondamine and 1 and 8 days after combined treatment with chlorisondamine and reserpine. Intact storage vesicles obtained from glands of untreated animals had a specific gravity of 1.27, while the membranes obtained from vesicles lysed in distilled water had a specific gravity of 1.12. Chlorisondamine had no effect on the total dopamine beta-hydroxylase and catecholamine content of the adrenal glands or on the buoyant density, even though there was a slight reduction of the activities in segments A and B of the gradients. Twenty-four hours after treatment with chlorisondamine plus reserpine there was a marked decrease in the catecholamine content, no change in the dopamine beta-hydroxylase activity, and a significant decrease in the buoyant density of the storage vesicles; the ratio of dopamine beta-hydroxylase to catecholamines in the purified storage vesicles was 2-3 times greater than those of untreated and chlorisondamine-treated animals. Eight days after treatment with reserpine and chlorisondamine the dopamine beta-hydroxylase activities were twice those of untreated animals, but the catecholamine content was only 60-70% of the control levels. At eight days the buoyant density of the storage vesicles was still significantly less than that of vesicles obtained from untreated rabbits, but not different from that of chlorisondamine-treated animals. These results suggest that recovery of the catecholamine content following reserpine administration requires synthesis of new storage vesicles, but this may not be the srate-limiting step in the recovery. Isopycnic centrifugation through sucrose density gradient provides a method for differentiating normally filled, partially filled, and empty storage vesicles.

Submitted on February 8, 1971




This article has been cited by other articles:


Home page
J. Neurosci.Home page
E. V. Mosharov, L.-W. Gong, B. Khanna, D. Sulzer, and M. Lindau
Intracellular Patch Electrochemistry: Regulation of Cytosolic Catecholamines in Chromaffin Cells
J. Neurosci., July 2, 2003; 23(13): 5835 - 5845.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
O. Viveros, C. Lee, M. Abou-Donia, J. Nixon, and C. Nichol
Biopterin cofactor biosynthesis: independent regulation of GTP cyclohydrolase in adrenal medulla and cortex
Science, July 17, 1981; 213(4505): 349 - 350.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics